Microglial effector pathways in the CNS

中枢神经系统中的小胶质细胞效应通路

• 批准号: 6697255
• 负责人: Styliani-Anna (Stella) E Tsirka
• 金额: $ 36.53万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-01-15 至 2006-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6697255
• 关键词: SDS polyacrylamide gel electrophoresis; annexins; autocrine; biological signal transduction; central nervous system; gene expression; genetically modified animals; hippocampus; immunocytochemistry; immunoprecipitation; laboratory mouse; mass spectrometry; microarray technology; microglia; neural degeneration; neuroeffector; paracrine; plasminogen activator; polymerase chain reaction; tissue /cell culture

DESCRIPTION (provided by applicant): Microglia, the immune cells of the central nervous system, undertake a number of different functional roles. One major role consists of participating in a signaling pathway that leads to excitatory neuronal death in acute (e.g., stroke), or chronic (e.g., Alzheimer's, amyotrophic lateral sclerosis, glaucoma) neurodegenerative diseases. We propose to investigate the process of microglial activation in this setting of excitotoxic neurodegeneration. Identification and characterization of genes involved in microglial activation could generate potential targets in the CNS for the rational design of new therapeutic approaches for intervention in these diseases. We propose to define, using DNA chip technology, the signaling cascades that result in microglial activation. Furthermore, we will make use of tissue plasminogen activator (tPA), a serine protease that is produced by neurons and microglia and that mediates microglial activation via interaction with a microglial cell surface receptor, annexin II. tPA will be used as a tool to dissect the process of activation, since it functions as an extracellular trigger to activate intracellular effectors. The signaling pathways that lead to microglial activation will be analyzed. This set of experiments will identify candidate targets for subsequent pharmaceutical study for inhibition or suppression of the neurotoxic properties of activated microglia.

描述（由申请人提供）：小胶质细胞，中枢神经系统的免疫细胞，承担许多不同的功能作用。一个主要作用包括参与导致急性（例如，中风），或慢性（例如，阿尔茨海默氏症、肌萎缩侧索硬化症、青光眼）神经变性疾病。我们建议调查的过程中，小胶质细胞激活在这种设置兴奋性神经变性。参与小胶质细胞活化的基因的鉴定和表征可以在CNS中产生潜在的靶点，用于合理设计用于干预这些疾病的新治疗方法。我们建议使用DNA芯片技术来定义导致小胶质细胞激活的信号级联。此外，我们将利用组织纤溶酶原激活剂（tPA），一种丝氨酸蛋白酶，由神经元和小胶质细胞产生，通过与小胶质细胞表面受体膜联蛋白II相互作用介导小胶质细胞活化。tPA将被用作剖析激活过程的工具，因为它作为激活细胞内效应物的细胞外触发物发挥作用。将分析导致小胶质细胞活化的信号通路。这组实验将确定用于随后的药物研究的候选靶标，用于抑制或抑制活化的小胶质细胞的神经毒性性质。